Global Optic Nerve Disorders Treatment Market Size and Forecast 2024-2033 | Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Novartis AG, Regeneron Pharmaceuticals Inc.

Overview and Scope

Optic nerve disorder treatment refers to the medical interventions and approaches aimed at diagnosing, managing and potentially improving or preserving the function of the optic nerve, which is responsible for transmitting visual information from the eye to the brain. This treatment is used to cure the condition where the patterns of visual loss are brought on by inherited or acquired abnormalities of the optic nerves.

Sizing and Forecast

The optic nerve disorders treatment market size has grown strongly in recent years. It will grow from $3.59 billion in 2023 to $3.81 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%.  The  growth in the historic period can be attributed to targeted therapies, telemedicine expansion, patient empowerment, global collaborative research.

The optic nerve disorders treatment market size is expected to see strong growth in the next few years. It will grow to $4.67 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%.  The growth in the forecast period can be attributed to personalized medicine, telemedicine and remote procedures, patient education and awareness, reimbursement policies. Major trends in the forecast period include artificial vision and bionic eye devices, optic nerve regeneration, integration of ai in ophthalmology, community-based vision programs.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

The optic nerve disorders treatment market covered in this report is segmented –

1) By Treatment Type: Steroidal Therapy; Immunomodulators therapy; Other Treatment Types
2) By Indication: Glaucoma; Optic Neuritis; Optic Neuropathy; Congenital Optic Atrophy; Other Indications
3) By End User: Hospitals; Ambulatory Surgery Centers; Clinics; Other End Users

North America was the largest region in the optic nerve disorders treatment market in 2023. The regions covered in optic nerve disorders treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=12997&type=smp

Major Driver Impacting Market Growth

The increase in the prevalence of eye disorders is expected to propel the growth of the optic nerve disorder treatment market going forward. Eye disorders refer to illnesses or conditions that affect the eyes’ tissues and other components. Optic nerve disorder treatment helps patients suffering from eye disorders treating various eye ailments, such as glaucoma by slowing down or preventing further optic nerve damage. For instance, in November 2022, according to the Centers for Disease Control and Prevention, a US-based government administration for public health, over 3 million Americans in the US were suffering from glaucoma. Additionally, it is anticipated that the figure would increase to 6.3 million by 2050. Therefore, the increase in the prevalence of eye disorders is driving the growth of the optic nerve disorder treatment market.

Key Industry Players

Major players in the optic nerve disorders treatment market are  Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Novartis AG, Regeneron Pharmaceuticals Inc., Alcon Inc., Sun Pharmaceutical Industries Limited, Bausch + Lomb Corporation, Horizon Therapeutics Inc., Santen Pharmaceutical Co. Ltd., Allergan Inc., Akorn Inc., Ionis Pharmaceuticals Inc., Lumenis Ltd., Glaukos Corporation, Nidek Co. Ltd., Aerie Pharmaceuticals Inc., Spark Therapeutics Inc., IRIDEX Corporation, Kowa Company Limited, New World Medical Inc., Heidelberg Engineering GmbH, Editas Medicine Inc., Quark Pharmaceuticals Inc., iSTAR Medical SA, Neurotech Pharmaceuticals Inc., Nicox SA., GenSight Biologics S.A., Inotek Pharmaceuticals Co., Oculis Holding AG.

The optic nerve disorders treatment market report table of contents includes:

1. Executive Summary

2. Optic Nerve Disorders Treatment Market Characteristics

3. Optic Nerve Disorders Treatment Market Trends And Strategies

4. Optic Nerve Disorders Treatment Market – Macro Economic Scenario

…

32. Global Optic Nerve Disorders Treatment Market Competitive Benchmarking

33. Global Optic Nerve Disorders Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Optic Nerve Disorders Treatment Market

35. Optic Nerve Disorders Treatment Market Future Outlook and Potential Analysis

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model